Skip to main content
PMC home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1985 Sep;20(3):211–218. doi: 10.1111/j.1365-2125.1985.tb05063.x

The effect of enalapril on baroreceptor mediated reflex function in normotensive subjects.

J F Giudicelli, A Berdeaux, A Edouard, C Richer, D Jacolot
PMCID: PMC1400702  PMID: 2994702

Abstract

The effects of enalapril, 20 mg orally, on the responses to baroreflex activation and deactivation by respectively phenylephrine and nitroglycerin were investigated in normotensive subjects on a normal sodium diet, with simultaneous measurement of plasma renin activity (PRA), converting enzyme activity (PCEA), aldosterone and catecholamines. Enalapril, 4 h after administration, lowered artificial blood pressure without modifying heart rate and plasma catecholamines. PCEA was abolished, PRA increased and plasma aldosterone decreased. Enalapril (a) displaced to the left the baroreflex set-point, (b) did not affect baroreflex sensitivity since the slopes of the RR-interval/systolic blood pressure regression lines remained unchanged during both activation and deactivation and (c) did not modify baroreflex efficacy since the maximal RR-interval responses as well as the overall RR-interval-time products to identical blood pressure variations were not modified. Thus, enalapril induced a resetting of the baroreflex, which probably accounts for the lack of reflex tachycardia observed during the drug-induced fall in blood pressure.

Full text

PDF
211

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bristow J. D., Honour A. J., Pickering G. W., Sleight P., Smyth H. S. Diminished baroreflex sensitivity in high blood pressure. Circulation. 1969 Jan;39(1):48–54. doi: 10.1161/01.cir.39.1.48. [DOI] [PubMed] [Google Scholar]
  2. Brown M. J., Jenner D. A. Novel double-isotope technique for enzymatic assay of catecholamines, permitting high precision, sensitivity and plasma sample capacity. Clin Sci (Lond) 1981 Nov;61(5):591–598. doi: 10.1042/cs0610591. [DOI] [PubMed] [Google Scholar]
  3. Casellas D., Mimran A., Dupont M., Chevillard C. Attenuation by SQ 14,255 (captopril) of the vascular response to noradrenaline in the rate isolated kidney. Br J Clin Pharmacol. 1980 Dec;10(6):621–623. doi: 10.1111/j.1365-2125.1980.tb00521.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cody R. J., Jr, Tarazi R. C., Bravo E. L., Fouad F. M. Haemodynamics of orally-active converting enzyme inhibitor (SQ 14225) in hypertensive patients. Clin Sci Mol Med. 1978 Nov;55(5):453–459. doi: 10.1042/cs0550453. [DOI] [PubMed] [Google Scholar]
  5. Cushman D. W., Cheung H. S. Spectrophotometric assay and properties of the angiotensin-converting enzyme of rabbit lung. Biochem Pharmacol. 1971 Jul;20(7):1637–1648. doi: 10.1016/0006-2952(71)90292-9. [DOI] [PubMed] [Google Scholar]
  6. Eckberg D. L. Nonlinearities of the human carotid baroreceptor-cardiac reflex. Circ Res. 1980 Aug;47(2):208–216. doi: 10.1161/01.res.47.2.208. [DOI] [PubMed] [Google Scholar]
  7. Ferrario C. M., Barnes K. L., Szilagyi J. E., Brosnihan K. B. Physiological and pharmacological characterization of the area postrema pressor pathways in the normal dog. Hypertension. 1979 May-Jun;1(3):235–245. doi: 10.1161/01.hyp.1.3.235. [DOI] [PubMed] [Google Scholar]
  8. Freslon J. L., Giudicelli J. F. Compared myocardial and vascular effects of captopril and dihydralazine during hypertension development in spontaneously hypertensive rats. Br J Pharmacol. 1983 Nov;80(3):533–543. doi: 10.1111/j.1476-5381.1983.tb10726.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Gavras H., Biollaz J., Waeber B., Brunner H. R., Gavras I., Davies R. O. Effects of the new oral angiotensin converting enzyme inhibitor MK-421 in human hypertension. Clin Exp Hypertens A. 1982;4(1-2):303–314. doi: 10.3109/10641968209061593. [DOI] [PubMed] [Google Scholar]
  10. Goldstein D. S. Arterial baroreflex sensitivity, plasma catecholamines, and pressor responsiveness in essential hypertension. Circulation. 1983 Aug;68(2):234–240. doi: 10.1161/01.cir.68.2.234. [DOI] [PubMed] [Google Scholar]
  11. Hatton R., Clough D., Faulkner K., Conway J. Angiotensin-converting enzyme inhibitor resets baroreceptor reflexes in conscious dogs. Hypertension. 1981 Nov-Dec;3(6):676–681. doi: 10.1161/01.hyp.3.6.676. [DOI] [PubMed] [Google Scholar]
  12. Ibsen H., Egan B., Osterziel K., Vander A., Julius S. Reflex-hemodynamic adjustments and baroreflex sensitivity during converting enzyme inhibition with MK-421 in normal humans. Hypertension. 1983 Mar-Apr;5(2 Pt 2):I184–I191. doi: 10.1161/01.hyp.5.2_pt_2.i184. [DOI] [PubMed] [Google Scholar]
  13. Imai Y., Abe K., Seino M., Haruyama T., Tajima J., Sato M., Goto T., Hiwatari M., Kasai Y., Yoshinaga K. Attenuation of pressor responses to norepinephrine and pitressin and potentiation of pressor response to angiotensin II by captopril in human subjects. Hypertension. 1982 May-Jun;4(3):444–451. doi: 10.1161/01.hyp.4.3.444. [DOI] [PubMed] [Google Scholar]
  14. Imai Y., Abe K., Yoshinaga K. The effect of captopril on heart rate in several types of hypertensive patients. Tohoku J Exp Med. 1981 Feb;133(2):243–244. doi: 10.1620/tjem.133.243. [DOI] [PubMed] [Google Scholar]
  15. Johnston C. I., Jackson B., McGrath B., Matthews G., Arnolda L. Relationship of antihypertensive effect of enalapril to serum MK-422 levels and angiotensin converting enzyme inhibition. J Hypertens Suppl. 1983 Oct;1(1):71–75. [PubMed] [Google Scholar]
  16. MacGregor G. A., Markandu N. D., Bayliss J., Roulston J. E., Squires M., Morton J. J. Non-sulfhydryl-containing angiotensin-converting enzyme inhibitor (MK421): evidence for role of renin system in normotensive subjects. Br Med J (Clin Res Ed) 1981 Aug 8;283(6288):401–403. doi: 10.1136/bmj.283.6288.401. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Mancia G., Parati G., Pomidossi G., Grassi G., Bertinieri G., Buccino N., Ferrari A., Gregorini L., Rupoli L., Zanchetti A. Modification of arterial baroreflexes by captopril in essential hypertension. Am J Cardiol. 1982 Apr 21;49(6):1415–1419. doi: 10.1016/0002-9149(82)90353-8. [DOI] [PubMed] [Google Scholar]
  18. McRitchie R. J., Vatner S. F., Heyndrickx G. R., Braunwald E. The role of arterial baroreceptors in the regulation of arterial pressure in conscious dogs. Circ Res. 1976 Nov;39(5):666–670. doi: 10.1161/01.res.39.5.666. [DOI] [PubMed] [Google Scholar]
  19. Millar J. A., Derkx F. H., McLean K., Reid J. L. Pharmacodynamics of converting enzyme inhibition: the cardiovascular, endocrine and autonomic effects of MK421 (enalapril) and MK521. Br J Clin Pharmacol. 1982 Sep;14(3):347–355. doi: 10.1111/j.1365-2125.1982.tb01990.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Pham-Huu-Trung M. T., Corvol P. A direct determination of plasma aldosterone. Steroids. 1974 Nov;24(5):587–508. doi: 10.1016/0039-128x(74)90013-0. [DOI] [PubMed] [Google Scholar]
  21. Randall O., Esler M., Culp B., Julius S., Zweifler A. Determinants of baroreflex sensitivity in man. J Lab Clin Med. 1978 Mar;91(3):514–519. [PubMed] [Google Scholar]
  22. Reid J. L., Millar J. A., Campbell B. C. Enalapril and autonomic reflexes and exercise performance. J Hypertens Suppl. 1983 Oct;1(1):129–134. [PubMed] [Google Scholar]
  23. Richer C., Doussau M. P., Giudicelli J. F. Effects of captopril and enalapril on regional vascular resistance and reactivity in spontaneously hypertensive rats. Hypertension. 1983 May-Jun;5(3):312–320. doi: 10.1161/01.hyp.5.3.312. [DOI] [PubMed] [Google Scholar]
  24. Simon A. C., Levenson J. A., Bouthier J. D., Benetos A., Achimastos A., Fouchard M., Maarek B. C., Safar M. E. Comparison of oral MK 421 and propranolol in mild to moderate essential hypertension and their effects on arterial and venous vessels of the forearm. Am J Cardiol. 1984 Mar 1;53(6):781–785. doi: 10.1016/0002-9149(84)90403-x. [DOI] [PubMed] [Google Scholar]
  25. Simon A. C., Safar M. E., Levenson J. A., Bouthier J. E., Benetos A. Action of vasodilating drugs on small and large arteries of hypertensive patients. J Cardiovasc Pharmacol. 1983 Jul-Aug;5(4):626–631. doi: 10.1097/00005344-198307000-00018. [DOI] [PubMed] [Google Scholar]
  26. Ulm E. H., Hichens M., Gomez H. J., Till A. E., Hand E., Vassil T. C., Biollaz J., Brunner H. R., Schelling J. L. Enalapril maleate and a lysine analogue (MK-521): disposition in man. Br J Clin Pharmacol. 1982 Sep;14(3):357–362. doi: 10.1111/j.1365-2125.1982.tb01991.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Warren S. E., O'Connor D. T., Cohen I. M. Autonomic and baroreflex function after captopril in hypertension. Am Heart J. 1983 Jun;105(6):1002–1008. doi: 10.1016/0002-8703(83)90403-9. [DOI] [PubMed] [Google Scholar]
  28. de Leeuw P. W., Hoogma R. P., van Soest G. A., Tchang P. T., Birkenhäger W. H. Humoral and renal effects of MK-421 (enalapril) in hypertensive subjects. J Cardiovasc Pharmacol. 1983 Sep-Oct;5(5):731–736. doi: 10.1097/00005344-198309000-00005. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES